Verona Pharma plc (NASDAQ:VRNA) Receives Average Recommendation of “Buy” from Analysts
Verona Pharma plc (NASDAQ:VRNA – Get Free Report) has earned an average rating of “Buy” from the seven brokerages that are presently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective […]
Verona Pharma plc (NASDAQ:VRNA – Get Free Report) has earned an average rating of “Buy” from the seven brokerages that are presently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective […]
